skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Calcium - Blood remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial

Block, Geoffrey A ; Bushinsky, David A ; Cheng, Sunfa ; Cunningham, John ; Dehmel, Bastian ; Drueke, Tilman B ; Ketteler, Markus ; Kewalramani, Reshma ; Martin, Kevin J ; Moe, Sharon M ; Patel, Uptal D ; Silver, Justin ; Sun, Yan ; Wang, Hao ; Chertow, Glenn M

JAMA : the journal of the American Medical Association, 2017-01, Vol.317 (2), p.156-164 [Periódico revisado por pares]

United States: American Medical Association

Texto completo disponível

Citações Citado por
2
Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism
Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism

Behets, Geert J. ; Spasovski, Goce ; Sterling, Lulu R. ; Goodman, William G. ; Spiegel, David M. ; De Broe, Marc E. ; D'Haese, Patrick C.

Kidney international, 2015-04, Vol.87 (4), p.846-856 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial
Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial

Floege, Jürgen ; Tsirtsonis, Kate ; Iles, Jan ; Drueke, Tilman B. ; Chertow, Glenn M. ; Parfrey, Patrick

Kidney international, 2018-06, Vol.93 (6), p.1475-1482 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism
Material Type:
Artigo 		Adicionar ao Meu Espaço

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism

Bushinsky, David A ; Chertow, Glenn M ; Cheng, Sunfa ; Deng, Hongjie ; Kopyt, Nelson ; Martin, Kevin J ; Rastogi, Anjay ; Ureña-Torres, Pablo ; Vervloet, Marc ; Block, Geoffrey A

Nephrology, dialysis, transplantation, 2020-10, Vol.35 (10), p.1769-1778 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
5
Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials
Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials

Block, Geoffrey A ; Bushinsky, David A ; Cunningham, John ; Drueke, Tilman B ; Ketteler, Markus ; Kewalramani, Reshma ; Martin, Kevin J ; Mix, T. Christian ; Moe, Sharon M ; Patel, Uptal D ; Silver, Justin ; Spiegel, David M ; Sterling, Lulu ; Walsh, Liron ; Chertow, Glenn M

JAMA : the journal of the American Medical Association, 2017-01, Vol.317 (2), p.146-155 [Periódico revisado por pares]

United States: American Medical Association

Texto completo disponível

Citações Citado por
6
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study

KETTELER, Markus ; MARTIN, Kevin J ; WOLF, Myles ; AMDAHL, Michael ; COZZOLINO, Mario ; GOLDSMITH, David ; SHARMA, Amit ; MARX, Steven ; KHAN, Samina

Nephrology, dialysis, transplantation, 2012-08, Vol.27 (8), p.3270-3278 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
7
A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients
A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients

Fukagawa, Masafumi ; Yokoyama, Keitaro ; Shigematsu, Takashi ; Akiba, Takashi ; Fujii, Akifumi ; Kuramoto, Takuto ; Odani, Motoi ; Akizawa, Tadao

Nephrology, dialysis, transplantation, 2017-10, Vol.32 (10), p.1723-1730 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
8
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

Block, Geoffrey A ; Martin, Kevin J ; de Francisco, Angel L.M ; Turner, Stewart A ; Avram, Morrell M ; Suranyi, Michael G ; Hercz, Gavril ; Cunningham, John ; Abu-Alfa, Ali K ; Messa, Piergiorgio ; Coyne, Daniel W ; Locatelli, Francesco ; Cohen, Raphael M ; Evenepoel, Pieter ; Moe, Sharon M ; Fournier, Albert ; Braun, Johann ; McCary, Laura C ; Zani, Valter J ; Olson, Kurt A ; Drüeke, Tilman B ; Goodman, William G

The New England journal of medicine, 2004-04, Vol.350 (15), p.1516-1525 [Periódico revisado por pares]

Boston, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
9
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis

Warady, Bradley A. ; Iles, Janet N. ; Ariceta, Gema ; Dehmel, Bastian ; Hidalgo, Guillermo ; Jiang, Xun ; Laskin, Benjamin ; Shahinfar, Shahnaz ; Vande Walle, Johan ; Schaefer, Franz

Pediatric nephrology (Berlin, West), 2019-03, Vol.34 (3), p.475-486 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
10
Pharmacology of Parsabiv® (etelcalcetide, ONO-5163/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patients
Pharmacology of Parsabiv® (etelcalcetide, ONO-5163/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacology of Parsabiv® (etelcalcetide, ONO-5163/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patients

Harada, Kazutsune ; Fujioka, Aiko ; Konno, Masakazu ; Inoue, Atsuto ; Yamada, Hiroyuki ; Hirota, Yasushi

European journal of pharmacology, 2019-01, Vol.842, p.139-145 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (368)
  2. Revistas revisadas por pares (433)

Data de Publicação 

De até
Refinar
  1. Antes de1978  (34)
  2. 1978Até1988  (27)
  3. 1989Até1998  (91)
  4. 1999Até2009  (201)
  5. Após 2009  (144)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (433)
  2. Japonês  (80)
  3. Espanhol  (13)
  4. Alemão  (11)
  5. Italiano  (9)
  6. Polonês  (7)
  7. Francês  (5)
  8. Português  (3)
  9. Chinês  (3)
  10. Dinamarquês  (2)
  11. Russo  (1)
  12. Lituano  (1)
  13. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.